Market capitalization | €267.69m |
Enterprise Value | €456.49m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.47 |
P/S ratio (TTM) P/S ratio | 0.28 |
P/B ratio (TTM) P/B ratio | 0.30 |
Revenue growth (TTM) Revenue growth | -2.44% |
Revenue (TTM) Revenue | €965.30m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
3 Analysts have issued a Euroapi forecast:
3 Analysts have issued a Euroapi forecast:
Jun '24 |
+/-
%
|
||
Revenue | 965 965 |
2%
2%
|
|
Gross Profit | 159 159 |
7%
7%
|
|
EBITDA | 72 72 |
23%
23%
|
EBIT (Operating Income) EBIT | 3.10 3.10 |
82%
82%
|
Net Profit | -287 -287 |
1,024%
1,024%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company was founded in 1976 and is headquartered in Antony, France.
Head office | France |
CEO | David Seignolle |
Employees | 3,669 |
Founded | 2020 |
Website | www.euroapi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.